The authors present a review of biomaterials, substances traditionally derived from human
or animal tissue or, more recently, biodegradable synthetics modeled after naturally …

Background Despite increasing literature support for the use of acellular dermal matrix
(ADM) in expander-based breast reconstruction, the effect of ADM on clinical outcomes in …

Background: Acellular dermal matrix was introduced in breast reconstruction in 2001 and is
gradually becoming a standard component for immediate breast reconstruction and nipple …

Background: Tissue reinforcement with allogeneic or xenogeneic acellular dermal matrices
(ADMs) is increasingly used in single-stage (direct-to-implant) and 2-stage implant-based …

Introduction: Reported infection rates in breast reconstruction with acellular dermal matrix
(ADM) can exceed 31%. Prophylactic antibiotics remain controversial due to the absence of …

Natural polymers have been widely used in a variety of biomedical applications such as
pharmaceuticals, tissue regeneration scaffolds, drug delivery agents, and imaging agents. In …

Background The current diversity of the available acellular dermal matrix (ADM) materials for
implant-based breast reconstruction raises the issue of whether there are any differences in …

Materials suitable for in situ tissue engineering (TE) include those that are either synthetic or
naturally occurring in composition. However, such materials must possess the following two …

Background Postmastectomy implant-based breast reconstruction (IBR) in the setting of
radiation (XRT) comes with a high risk of perioperative complications regardless of …

Of the nearly 90,000 implant-based breast reconstructions performed in the United States,
the majority use internal soft-tissue support. Aesthetically, these constructs may allow for …